Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors without effective diagnostic biomarkers. This study intended to dynamically analyze serum proteomics in different pathological stages of liver diseases, and discover potential diagnostic biomarkers for early HCC. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiao, Jing, Rui, Zhong, Jian-Hong, Dong, Xin, Li, Yun-Xi, Liu, Yin-Kun, Huang, Tian-Ren, Zhang, Chun-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617482/
https://www.ncbi.nlm.nih.gov/pubmed/28977922
http://dx.doi.org/10.18632/oncotarget.18782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617482/
https://www.ncbi.nlm.nih.gov/pubmed/28977922
http://dx.doi.org/10.18632/oncotarget.18782

Ejemplares similares